Biophage Pharma Inc. Initiates Performance And Validation Testing Of PDS96(R) Biosensor

MONTREAL, Dec. 6 /CNW Telbec/ - (TSX.V: BUG) - Biophage Pharma Inc. reported today that it has reached an important milestone in the development of a compact PDS96(R) Biosensor. The company is now conducting extensive in-house performance testing and validation of the alpha prototype, and expects to file US and PCT patents in the first quarter of 2007.
MORE ON THIS TOPIC